The Latest Headlines at American Banking and Market News
Wells Fargo & Company Lowers Annexon (NASDAQ:ANNX) Price Target to $10.00
Annexon (NASDAQ:ANNX – Get Free Report) had its price target reduced by investment analysts at Wells Fargo & Company from $12.00 to $10.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has... More of this article »
StockNews.com Downgrades Sphere 3D (NASDAQ:ANY) to Sell
Sphere 3D (NASDAQ:ANY – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday. Sphere 3D Stock Performance Sphere... More of this article »
Research Analysts’ Weekly Ratings Changes for Willis Towers Watson Public (WTW)
Several analysts have recently updated their ratings and price targets for Willis Towers Watson Public (NASDAQ: WTW): 5/6/2024 – Willis Towers Watson Public had its price target lowered by analysts at Keefe, Bruyette &... More of this article »
FY2025 EPS Estimates for Amcor plc Decreased by Zacks Research (NYSE:AMCR)
Amcor plc (NYSE:AMCR – Free Report) – Equities researchers at Zacks Research cut their FY2025 earnings estimates for Amcor in a report issued on Tuesday, May 14th. Zacks Research analyst M. Das now forecasts that the... More of this article »
Banc of California, Inc. (NYSE:BANC) Expected to Earn FY2025 Earnings of $1.90 Per Share
Banc of California, Inc. (NYSE:BANC – Free Report) – Wedbush decreased their FY2025 earnings per share estimates for Banc of California in a report released on Monday, May 13th. Wedbush analyst D. Chiaverini now expects... More of this article »
Leerink Partnrs Research Analysts Lower Earnings Estimates for Enhabit, Inc. (NYSE:EHAB)
Enhabit, Inc. (NYSE:EHAB – Free Report) – Stock analysts at Leerink Partnrs dropped their FY2025 earnings estimates for shares of Enhabit in a research note issued on Tuesday, May 14th. Leerink Partnrs analyst W. Mayo... More of this article »
HC Wainwright Analysts Increase Earnings Estimates for Fennec Pharmaceuticals Inc (NASDAQ:FENC)
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) – Investment analysts at HC Wainwright upped their FY2025 earnings estimates for Fennec Pharmaceuticals in a research note issued to investors on Wednesday, May... More of this article »
Research Analysts Offer Predictions for Gogo Inc.’s FY2025 Earnings (NASDAQ:GOGO)
Gogo Inc. (NASDAQ:GOGO – Free Report) – Analysts at William Blair increased their FY2025 earnings per share (EPS) estimates for Gogo in a report issued on Monday, May 13th. William Blair analyst L. Dipalma now expects... More of this article »
HC Wainwright Comments on Intrusion Inc.’s FY2025 Earnings (NASDAQ:INTZ)
Intrusion Inc. (NASDAQ:INTZ – Free Report) – HC Wainwright issued their FY2025 EPS estimates for shares of Intrusion in a report issued on Wednesday, May 15th. HC Wainwright analyst S. Buck anticipates that the company... More of this article »
FY2025 Earnings Forecast for Construction Partners, Inc. (NASDAQ:ROAD) Issued By DA Davidson
Construction Partners, Inc. (NASDAQ:ROAD – Free Report) – Research analysts at DA Davidson raised their FY2025 earnings per share (EPS) estimates for Construction Partners in a research report issued on Tuesday, May... More of this article »
Q3 2025 EPS Estimates for iPower Inc. (NYSE:IPW) Lifted by Roth Capital
iPower Inc. (NYSE:IPW – Free Report) – Investment analysts at Roth Capital increased their Q3 2025 earnings per share (EPS) estimates for shares of iPower in a research report issued to clients and investors on Wednesday,... More of this article »
FY2025 Earnings Forecast for Tecnoglass Inc. (NASDAQ:TGLS) Issued By DA Davidson
Tecnoglass Inc. (NASDAQ:TGLS – Free Report) – Stock analysts at DA Davidson dropped their FY2025 earnings estimates for Tecnoglass in a note issued to investors on Tuesday, May 14th. DA Davidson analyst B. Thielman... More of this article »
Equities Analysts Offer Predictions for Apellis Pharmaceuticals, Inc.’s Q2 2025 Earnings (NASDAQ:APLS)
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Stock analysts at Wedbush issued their Q2 2025 earnings per share estimates for Apellis Pharmaceuticals in a report issued on Wednesday, May 15th. Wedbush... More of this article »